000172719 000__ 01295fam\a2200289\a\4500
000172719 001__ 172719
000172719 005__ 20220217103503.0
000172719 008__ 890203s1989\\\\dcuak\\\\b\\\f00000\eng\d
000172719 035__ $$9(IS)TVJ1771
000172719 035__ $$9AAU0577SI
000172719 035__ $$a172719
000172719 040__ $$aGPO$$cGPO
000172719 043__ $$an-us---
000172719 074__ $$a1016-A, 1016-B (microfiche)
000172719 0860_ $$aY 4.G 74/7:D 84/24
000172719 099__ $$aY 4.G 74/7:D 84/24
000172719 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Government Operations.$$bHuman Resources and Intergovernmental Relations Subcommittee.
000172719 24510 $$aTherapeutic drugs for AIDS :$$bdevelopment, testing, and availability : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, April 28 and 29, 1988.
000172719 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,$$c1988 [i.e. 1989]
000172719 300__ $$av, 448 p. :$$bill., form ;$$c24 cm.
000172719 500__ $$aDistributed to some depository libraries in microfiche.
000172719 500__ $$aShipping list no.: 89-61-P.
000172719 504__ $$aIncludes bibliographies.
000172719 650_0 $$aAIDS (Disease)$$xTreatment$$zUnited States.
000172719 650_0 $$aAIDS (Disease)$$zUnited States$$xPrevention.
000172719 650_0 $$aDrugs$$zUnited States$$xTesting.
000172719 85230 $$bdfich$$hY 4.G 74/7:$$iD 84/24
000172719 909CO $$ooai:library.usi.edu:172719$$pGLOBAL_SET
000172719 948__ $$ac:jk
000172719 980__ $$aBIB
000172719 980__ $$aGOV RESOURCE